Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06262438
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2024-01-26
Brief Title:
CHIP-AML22Quizartinib Quizartinib Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD and NPM1wt AML Patients
Sponsor:
Princess Maxima Center for Pediatric Oncology
Organization:
Princess Maxima Center for Pediatric Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-26
First Submit QC Date:
February 7 2024
Study First Post Date:
2024-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-07
Last Update Post Date:
2024-02-16
Last Update Post Date Type:
ACTUAL